Drosophila enhancer-Gal4 lines show ectopic expression during development by Casas-Tinto, S. et al.
rsos.royalsocietypublishing.org
Research
Cite this article: Casas-Tintó S, Arnés M,
Ferrús A. 2017 Drosophila enhancer-Gal4 lines
show ectopic expression during development.
R. Soc. open sci. 4: 170039.
http://dx.doi.org/10.1098/rsos.170039
Received: 13 January 2017
Accepted: 27 February 2017
Subject Category:
Genetics
Subject Areas:
cellular biology/genetics/developmental
biology
Keywords:
gene expression, neuroscience, Drosophila,
development, Gal4
Author for correspondence:
Sergio Casas-Tintó
e-mail: scasas@cajal.csic.es
†Co-first author.
Electronic supplementary material is available
online at https://doi.org/10.6084/m9.figshare.
c.3716290.
Drosophila enhancer-Gal4
lines show ectopic
expression during
development
Sergio Casas-Tintó†, Mercedes Arnés† and
Alberto Ferrús
Cajal Institute-CSIC, Ave. Doctor Arce 37, Madrid 28002, Spain
SC-T , 0000-0002-9589-9981
In Drosophila melanogaster the most widely used technique to
drive gene expression is the binary UAS/Gal4 system. We
show here that a set of nervous system specific enhancers
(elav, D42/Toll-6, OK6/RapGAP1) display ectopic activity
in epithelial tissues during development, which is seldom
considered in experimental studies. This ectopic activity is
variable, unstable and influenced by the primary sequence of
the enhancer and the insertion site in the chromosome. In
addition, the ectopic activity is independent of the protein
expressed, Gal4, as it is reproduced also with the expression
of Gal80. Another enhancer, LN2 from the sex lethal (Sxl)
gene, shows sex-dependent features in its ectopic expression.
Feminization of LN2 expressing males does not alter the
male specific pattern indicating that the sexual dimorphism
of LN2 expression is an intrinsic feature of this enhancer.
Other X chromosome enhancers corresponding to genes not
related to sex determination do not show sexual dimorphism in
their ectopic expressions. Although variable and unstable, the
ectopic activation of enhancer-Gal4 lines seems to be regulated
in terms of tissue and intensity. To characterize the full domain
of expression of enhancer-Gal4 constructs is relevant for the
design of transgenic animal models and biotechnology tools,
as well as for the correct interpretation of developmental and
behavioural studies in which Gal4 lines are used.
1. Introduction
The yeast transcription factor Gal4 in combination with artificial
gene constructs placed under the control of UAS regulatory
sequences became a powerful experimental tool when converted
into transgenes in other species [1–3]. In Drosophila, this binary
UAS/Gal4 system has been extensively used for over two decades
[1]. The specificity of the expression domains of Gal4 lines has
allowed cellular resolution in most of these studies, representing
2017 The Authors. Published by the Royal Society under the terms of the Creative Commons
Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted
use, provided the original author and source are credited.
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a major advance over the formerly used genetic mosaics obtained by somatic recombination [4,5]. Beyond
the cellular studies, mostly addressing developmental questions, the UAS/Gal4 system has been used
also for organismal studies in the fields of neurobiology and behaviour [6–9]. In all cases, however, the
space and time specificity of the Gal4 line was the cornerstone of the experiment rationale. Thus, Gal4
lines were described on the bases of their canonical expression domains using a UAS reporter referred
to one or several developmental stages. These domains were interpreted as instructions dictated by
enhancers located nearby the site of insertion of the Gal4 construct. These lines are generally known
as enhancer trap Gal4 lines. In addition, characterized enhancers of a given gene were used to create
Gal4 lines with the desired expression domain [10,11]. These lines are referred to as synthetic promoter
Gal4 lines.
Enhancers are short (up to 400-bp) DNA sequences that can activate transcription at target
promoters located in their vicinity [12–14]. The first transcriptional enhancer was characterized more
than 30 years ago, when a viral DNA sequence was shown to activate transcription of the rabbit
haemoglobin beta1 gene, independently from its orientation and position relative to the promoter [15,16].
Eukaryotic chromatin can loop to permit enhancer–promoter interactions in still poorly understood
three-dimensional structures [14,17]. Recent genomic studies using various versions of 3C and 4C
chromatin immunoprecipitation assays revealed the widespread phenomenon of gene regulation by
enhancers while other studies identified specific signatures (histone modifications and associated
proteins) of enhancers that greatly facilitate analysis of the databases (reviewed in [18]).
To determine if the expression domains of Gal4 lines are constant along time, and as specific as
reported, we analysed several Drosophila lines considered to be nervous system specific. Most of them
showed transient expression in other tissues. This ectopic activation of enhancers, however, did not
necessarily imply the expression of the corresponding genes. Pressure to find utilitarian uses of the
limited knowledge on the normal mechanisms of gene expression has led to the production of enhancer-
based genetic tools intended to drive expression of engineered genes. However, the range of spurious
effects of these applications is rarely analysed in depth, and this justifies further efforts to study how
enhancers, both native and synthetic, attain their expression domains.
On the other hand, the temporal analysis of the expression domain of native and synthetic enhancers
may help to understand the dynamic process of gene expression along development. Contrary to the
widely accepted view that gene expression is a deterministic event, meaning that the final outcome is
determined by the initial conditions, our results seem to favour the proposal that, during development,
enhancers undergo changing molecular conditions that trigger their variable and ectopic expression. The
variability of these conditions is progressively reduced leading to two mutually exclusive events, the
extinction of the enhancer’s aberrant expression or the consolidation of its canonical expression domain
which finally allows transcription of the corresponding native gene and, thus, cell fate determination.
2. Results
We selected a collection of Drosophila enhancer-Gal4 lines (electronic supplementary material, table S1)
described in the literature to be active specifically in the nervous system, to determine if their
expression pattern was indeed restricted to the nervous system all along development. For this study we
analysed three different scenarios: (i) the activation of enhancers in the original position [E in electronic
supplementary material, table S1, elavc155, D42, OK6, NP2426 (LN2), c105, 796 and Repo], (ii) enhancers
with their corresponding promoter built into transgenic reporters [P in electronic supplementary
material, table S1, elav (II), elav (III) and phantom]; and (iii) enhancers with a synthetic promoter (P-DSCP
in electronic supplementary material, table S1, GMR10B11 and GMR 78G09) (electronic supplementary
material, figure S1).
The G-TRACE technique has been instrumental in this study [19]. Briefly summarized, it consists of
three constructs that contain: UAS-RFP fluorescent protein, UAS-Flipase and Act-FRT-STOP-FRT-GFP,
respectively. The system reports the temporal activation of the enhancer-Gal4 under study (figure 1a,
modified from [19]). The enhancer-Gal4 activity induces the expression of the UAS-Flipase (Flp) and UAS-
RFP (red) constructs. The Flp enzyme recognizes FRT sites and removes the STOP cassette, allowing the
expression of Act>GFP (green) in these cells and their progeny. Thus, we can determine the current
expression of an enhancer-Gal4 at the moment of dissection (red, RFP) and its historical expression
during development (Act>GFP (green)). The inventors of this technique showed already that some
enhancer-Gal4 lines exhibit divergence of activity at different stages of development within the same
tissue [19].
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Figure 1. Activation of the neural elav enhancer in wing disc cells. (a) Schematic description of the G-TRACE technique. An enhancer
controls the expression of Gal4 (blue) which results in a red reporter signal (RFP). This red signal will be maintained as long as the
enhancer is active, thus, it reflects the current expression domain. On the other hand, the first time in development when the enhancer
becomes active the flipase encoding construct is also activated (black box). The flipase, through the excision of a STOP cassette (black
triangles), allows the expression of a GFP-encoding construct (green box). This reporter is now controlled by a ubiquitous p63 promoter,
thus becoming independent from the original enhancer. This GFP reporter signal represents the historical expression domain. (b–e) G-
TRACE data from elav enhancer in larval brains (b,c) and wing discs (d,e). Note that the enhancer is not CNS specific. (f–i) In vivo images
of early developmental stages activation of elav enhancer in first instar (f,g) and second instar (h,i) larvae. (j–o) Quantification (j) of G-
TRACE pattern of elav enhancer comparing two different elav-Gal4 insertions, chromosome II (k–m) and chromosome III (n,o). Note that
the ectopic elav enhancer expression in the wing disc is not consistent between left and right sides of the same animal. This is evidence
of the variable nature of the ectopic expression. (p) Gal4mRNA quantitative RT-PCRs from chromosome II and chromosome III elav-Gal4
lines. (q,r) G-TRACE data for elav enhancer (q) and anti-ELAV staining (r) in larval brain. (s,t) G-TRACE data for elav enhancer (s) and anti-
ELAV staining (t) in larval wing imaginal disc. Note that the ELAV protein is CNS specific. Scale bar, 50 µm. Statistics: t-test *p< 0,05.
n= 5 wing discs/sample. Arrows in (e) indicate active enhancer cells (RFP).
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2.1. The nervous system elav enhancer is active in epithelial cells
The Drosophila gene elav, orthologue of human ELAVL gene family, is expressed throughout the brain
[20–24]. We confirmed the reported elav-Gal4 expression in brain neurons (figure 1b,c). The current (red)
and historical (green) records of elav enhancer activity show a high correspondence between both signals.
These data indicate that cells fated to be neurons in the brain are determined during development, and
that this fate is maintained during CNS development.
To determine the specificity of this elav enhancer, we analysed also epithelial tissues. The data showed
unexpected widespread GFP positive cells (figure 1d) and randomly distributed RFP positive cells in
wing imaginal discs (figure 1e) compared to the negative control (sibling flies without the Gal4 construct)
(electronic supplementary material, figure S2a,b). In addition, we analysed the elav-Gal4 enhancer using
the Act>STOP>Gal4; UAS-GFP line (see Materials and methods). The data show that elav enhancer is
active in wing imaginal disc cells (electronic supplementary material, figure S2c,d) consistent with the
previous result. To further validate the initial observation, we used another Gal4 line inserted adjacent to
the endogenous elav-Gal4 enhancer (elavc155) and the G-TRACE reporter line inserted in chromosome III.
In this case, GFP and RFP positive cells were also identified in the wing disc in a pattern similar to the
one shown by the previous elav construct. Moreover, a detailed analysis of elav enhancer activation also
showed activity in halter and leg imaginal discs and tracheal cells (electronic supplementary material,
figure S2e–l). Together, these results indicate that the elav enhancer, both in foreign or native locations,
is active in epithelial cells during development (GFP cells) and maintains its activity by the third
larval instar, albeit to a lesser extent [RFP cells are fewer than GFP cells (electronic supplementary
material, figure S2f–l)]. It seems that some wing disc cells switched on this enhancer sometime early
in development and still maintained it on by third larval instar (GFP + RFP, yellow cells), while others
have switched it off (GFP, green only cells) and others have switched it on lately (RFP, red only cells).
Most likely, the RFP signal (red only), occurred several hours before wing discs fixation/dissection and
has not had the time to express the FRT/FLP-GFP reporter, a sequential process that takes longer than
the RFP reporting (figure 1a).
To determine at what stage during development this ectopic enhancer activation occurs, we analysed
first and second instar larvae (24 and 48 h after egg laying, AEL) (figure 1f–i). G-TRACE reporters
showed that the elav enhancer is active as early as first (figure 1f,g) and second (figure 1h,i) instar larvae.
Red and green cells are found in the wing disc suggesting that the enhancer activity is triggered at the
initial stages of development in this cell system.
To further analyse the temporal activation of elav enhancer in this ectopic domain, we used wg-Gal4
(wingless) in combination with the G-TRACE system. In second instar larvae, wg expression is confined to
the wing pouch of the wing imaginal disc (electronic supplementary material, figure S2m). However, later
during development, this domain is restricted to concentric rings in third instar larval discs (electronic
supplementary material, figure S2n) [25,26]. These two different expression patterns allowed us to define
the temporal activation of the elav enhancer. We combined wg-Gal4/G-TRACE with a repressor of Gal4
activity, Gal80, under the regulation of elav enhancer, aiming to determine the activation of elav enhancer
by the effect of elav-Gal80 suppressor on wg-Gal4/G-TRACE pattern. Our results confirm that the wg
enhancer is active early during development in wing pouch cells (green in electronic supplementary
material, figure S2o,p) and, at the third instar larvae stage, it is restricted to its canonical wg domain
(green in electronic supplementary material, figure S2n and yellow in electronic supplementary
material, figure S2o,p). Also, elav-Gal80 eliminates the GFP signal corresponding to early wg-Gal4
activity, suggesting that the elav enhancer is active during the early stages of development. However,
elav-Gal80 does not suppress RFP signal at third instar stage (electronic supplementary material,
figure S2q,r), confirming that the elav enhancer is active during early stages of development in the
wing disc.
Next, to discard an effect due to the chromosomal site of insertion, we compared G-TRACE patterns
of the same elav-Gal4 construct but inserted in two different sites: chromosome II and chromosome
III (electronic supplementary material, table S1). All experiments were carried out in parallel and the
results indicate that both elav-Gal4 enhancer insertions have activity during development (GFP cells in
figure 1j–o). However, the insertion in chromosome II is expressed in 60% of the wing cells while the
insertion in chromosome III is expressed in 80% of them (figure 1j). Moreover, chromosome III insertion
has RFP-reported activity in 20% of wing cells (figure 1j,n,o) but activity for the chromosome II insertion
is restricted to less than 1% cells (figure 1j,k,l). In summary, the data indicate that even though the elav
enhancer shows ectopic expression in epithelial cells always, the genomic insertion site affects the extent
of this ectopic domain.
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We noticed that the expression pattern of GFP throughout different discs is not reproducible in
different larvae. This variability could result from heterogeneous environmental conditions among
individuals or cell systems. To further evaluate this feature, we compared left and right wing discs from
the same individual. Although the number of GFP positive cells is roughly comparable between the
two wing discs of the same animal, the pattern differs (figure 1k–o). This result supports the notion
that the enhancer activation during development is not deterministic. We cannot ascertain whether
the GFP positive cells activated the elav enhancer on a cell autonomous manner, or if they constitute
a lineage from one or very few cells that activated the enhancer early in development. However, the
fact that the expression pattern is highly variable within the same animal suggests that this is actually
a non-clonal event.
Concerning the canonical domain of expression in the CNS, both insertions of the elav enhancer
show the same pattern in brain cells. However, we addressed possible differences in the intensity of this
expression by qRT-PCR. The data show that the expression of the chromosome III insertion is five times
higher than that of the chromosome II (figure 1p). Together, it seems that the insertion site determines the
extent of the ectopic domain as well as the intensity of its expression.
Finally, to determine if the ectopic wing disc expression of the elav enhancer induces the expression
of the ELAV protein, we stained larval tissues with a specific anti-ELAV antibody. Third instar larval
brains show that, as expected, elav enhancer is active in neurons (figure 1q) and brain cells express ELAV
protein (figure 1r). However, while wing discs show elav enhancer activity (figure 1s), we did not detect
ELAV protein (figure 1t). These results indicate that the ectopic activation of elav enhancer does not lead
to detectable protein expression.
2.2. Toll-6 and OK6 neuronal enhancers are transiently active in epithelial cells
in early development
To assess if the phenomenon observed with the elav enhancer is general to other enhancers, we selected
additional cases also described as CNS specific. Line D42-Gal4 corresponds to a Toll-6 gene enhancer [27].
As described, neurons from the third instar larval brain had activated D42 during early development
(historical GFP, figure 2a, compared to current RFP, figure 2b). Similar to elav, D42 is also activated in
wing disc cells during early development but not in third instar larvae (no RFP cells) (figure 2c,d). In
addition, D42-Gal4 domain in the wing disc is also different between left and right discs within the same
animal (figure 2c,d). The historical GFP positive cells in the vicinity of the anterior–posterior (A/P) border
of the wing disc appear to align with the A/P compartment border. To determine if this is the case, we
stained for β-galactosidase in dpp-LacZ expressing discs that mark this boundary (figure 2e,f ). The GFP
cells distribution does not correspond with the dpp enhancer signal.
OK6-Gal4 is another widely used Gal4 line expressed in motor neurons [27] and the Gal4 insertion
is located 34 base pairs upstream of the transcription start site of the RapGAP1 gene (see electronic
supplementary material, table S1). We investigated the expression pattern of this driver (electronic
supplementary material, figure S3). As reported, OK6 is active in the brain (electronic supplementary
material, figure S3a–c), but there are GFP positive cells in the wing discs also (electronic supplementary
material, figure S3d–f ), revealing earlier activity of this enhancer. Comparing the wing disc expression
of the three enhancers, elav, D42 and OK6, it is important to realize that the extent of their ectopic
expressions is different among them. Thus, ectopic enhancer activity in wing cells is a variable and
general phenomenon characteristic of each enhancer and its genomic site.
To discard that the expressions identified by G-TRACE could result from a leaky Gal4 expression,
we repeated some experiments incorporating the Gal4 repressor, Gal80. We combined D42>G-TRACE
with elav-Gal80 and analysed the GFP and RFP reporters. Signals in the brain are silenced by elav-Gal80
(figure 2g compared to figure 2a,b). This is a validation of the Gal80 effect on the canonical D42 expression
domain in the brain. Next, to validate the inhibitory activity of elav-Gal80 during the enhancer ectopic
activation, we analysed the wing discs. The ectopic wing expression (figure 2c,d) is also fully repressed by
elav-Gal80 (figure 2h). This result confirms that the phenomenon of ectopic expression is not dependent
on the protein expressed, Gal4 or Gal80, but it is a property of the enhancer and its environment.
Next, to determine the temporal activation of the D42 enhancer, we used a thermo-sensitive form
of the repressor, Gal80TS, (electronic supplementary material, figure S4) and analysed the resulting G-
TRACE pattern. As controls, we maintained the larvae at 17°C (negative control, figure 2i) or at 29°C
(positive control, figure 2j). The negative control shows no G-TRACE signal and the positive control
yields the full enhancer expression in the brain. We set five time points (OFF, 12hOFF, 24hOFF, 48hOFF
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Figure 2. Toll-6 enhancer in brain andwing cells during development. (a–d) G-TRACE signal from third instar larval brain (a,b) andwing
disc (c,d) of the D42-Gal4 line inserted in Toll-6. (e,f ) Historical expression of D42 enhancer (GFP) versus LacZ-reported Dpp expression
(Dpp-LacZ, magenta). (g,h) elav-Gal80 suppresses D42-Gal4 activity in the brain (g) and wing disc (h). (i–o) Temporal expression
experiments in D42-Gal4>G-TRACE>tub-Gal80TS brain (i,j) and wing discs (k–o) maintained at 17°C ‘OFF’ (Gal4 silenced), 48 h, 24 h
or 12 h OFF or maintained at 29°C ‘ON’ (Gal4 active). (p) Quantification of GFP positive cells per time point. Student’s t-test *p< 0.05.
n= 5 wing discs/time point. Bar in (c)= 50 µm.
and ON) corresponding to the hours that the system is kept at the restrictive temperature and, hence,
silenced (electronic supplementary material, figure S4). The data show that, if the system is silenced
during 48 h, 24 h or 12 h of larval development, the ectopic expression of D42 does not occur (figure 2k–p).
Thus, D42 activation occurs during the first 12 hours of larval development, mainly.
2.3. The ectopic activation of enhancers does not lead to expression of their native gene
To determine if the ectopic enhancer expression implies a transient expression of the corresponding
native gene, we induced apoptosis by driving a core component of the JNK pathway, Basket (Bsk), [28]
under D42-Gal4 control. Wing imaginal discs were stained with anti-caspase 3 (C3) to detect apoptosis,
and with anti-Wingless (WG) to monitor wing disc development. Epithelial activation of D42-Gal4/Toll-6
leads to Bsk-dependent apoptosis, as revealed by C3 staining, and to abnormalities in the Wg immune
pattern which resulted in defective adult wings (figure 3a–f ). Further, to resolve if Toll-6 gene expression
is necessary for the development of the wing disc, we expressed a Toll-6 specific RNAi under the control
of D42-Gal4. We did not detect any apoptosis or morphological defect and the Wg expression pattern
was normal (figure 3g,h). To further demonstrate if Toll-6 is necessary for wing development, we used
an independent Gal4 (engrailed, en) to drive Toll-6 RNAi expression in the posterior compartment of the
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Figure 3. D42 enhancer is expressed in wing cells but its gene Toll-6 is not. (a–d) Caspase 3 (C3) (green) and Wingless expression (red)
in wild-type (a,b) and D42-Gal4>Bsk (c,d). Note the extensive apoptosis (c) and distorted Wg pattern (d) caused by Bsk. (e,f ) Resulting
adult wings with morphological abnormalities due to the Bsk-elicited apoptosis. (g–j) Caspase 3 (C3) (green) andWingless pattern (red)
in D42>Toll-6 RNAi (g,h) wing disc. (i,j) Wingless pattern (red) in en>Toll-6 RNAi (GFP) wing disc. (k,l) Resulting adult wings. Note the
lack of morphological effects after inactivating Toll-6 in the posterior wing. (m,n) Toll-6-GFP protein trap (Mi{MIC}Toll-6MI02127) shows
signal in larval brain (m) but not in imaginal discs (n). (o,p) Control and Toll-6ex16 mutant adult wings. Cell nuclei are marked in blue
(DAPI).
wing disc (GFP in figure 3i–l). The expression of this RNAi with this independent driver did not affect
the wing in any noticeable feature. Next, we used a Toll-6-GFP protein trap (Mi{MIC}Toll-6MI02127) to
detect endogenous Toll-6 protein expression. We observed the canonical Toll-6-GFP signal in the brain
(figure 3m). However, no signal was detected in imaginal disc (figure 3n). These results are in line with
reported data showing no detectable Toll-6 mRNA in wing imaginal discs [29]. To further determine that
Toll-6 expression is dispensable for wing development, we compared wild-type and Toll-6ex13 mutant
wings (figure 3o,p). Mutant wings do not display morphological defects indicating that Toll-6 expression
is not necessary for wing development. Thus, even though the Toll-6 enhancer D42 is active in the wing
disc during development, Toll-6 is not switched on in the wing, at least to the point of manifesting a
visible phenotype in disc size, shape or Wg pattern.
2.4. Sequence-dependent enhancer activation
We aimed to determine the contribution of the enhancer’s sequence to its unstable early activation. To
that end, we took advantage of the enhancer-Gal4 insertions directed to the exact same and insulated
chromosomal site with no detectable Gal4 basal activity [30]. Under these conditions, promoters are
subject to the same chromatin structural determinants except for the enhancer nucleotide sequence.
We compared two same-site/different-sequence insertions: GMR10B11 and GMR78G09 (see electronic
supplementary material, table S1). Both insertions are in the 3 L chromosome arm (68A4 polytene
band) and show specific activity in the nervous system. G-TRACE experiments confirmed that both
enhancer domains are restricted to the nervous system during development. Nevertheless, although
GMR10B11 is active in larval brain cells, its historical (GFP) and current (RFP) expressions are not
identical (figure 4a–c). This demonstrates that GMR10B11 expression is transient in certain larval brain
cells. GMR78G09 is also expressed in the brain although in fewer cells (about 28 cells, RFP, in third
instar larvae). In this case, a group of about 14 cells activated this enhancer in the ventral ganglion
8rsos.royalsocietypublishing.org
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during development but not at third instar larvae (figure 4d–f, arrowheads). These results indicate that
the nucleotide sequence of the enhancer is determinant to establish the time and number of cells that
will display transient expression during development. In the cases of GMR10B11 and GMR78G09 the
non-canonical expression domain is transient but not ectopic since it occurs within the same tissue.
2.5. Do all nervous system enhancers have epithelial ectopic activity?
Among the nervous system Gal4 enhancers tested here (electronic supplementary material, table S1) we
observed that some enhancers were restricted to the nervous system and showed no activity in wing
imaginal disc cells. Enhancers such as GMR78G09 were restricted to a few cells in the larval brain
(figure 4d–f ), showing a reduced number of cells with historical expression, which is different from
the expression at the moment of dissection (third instar larvae). To verify if some enhancers are less
susceptible to ectopic activity than others, we searched for Gal4 constructs whose activity in the mature
adult brain is restricted to the brain. c105-Gal4 is active in a small number of cells during pupariation
and adulthood [8] (see figure 4g–i and electronic supplementary material, table S1) and GH298-Gal4 is
active in local olfactory interneurons from larva and adult brain [31,32] (see figure 4j–l and electronic
supplementary material, table S1). Our G-TRACE data show that there are some GFP positive cells
dispersed in the adult brain and two groups of cells that had transient activity of the enhancer c105
(figure 4g–i, arrowheads). Also, GH298 was active in clusters of cells along the brain (GFP) (figure 4j–l,
arrowheads). We could not detect ectopic expression in other tissues for these two enhancers.
Further, we searched for domains that are active in a large number of brain cells but with a cellular
identity different from neurons. The gene reverse polarity (repo) is active in glial cells and their precursors
during development and throughout adulthood. repo-Gal4 G-TRACE experiments show specific activity
in the brain (electronic supplementary material, figure S5) with a full correspondence between historical
and actual enhancer activity. Moreover, no ectopic expression could be detected in epithelial wing disc
cells. That is, the enhancer repo represents a case with neither ectopic nor transient expression. Thus,
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Figure 5. The neurosecretory cells specific phantom enhancer. (a,b) Neurosecretory cells of the larval prothoracic gland expressing the
phantom-Gal4 enhancer. The expression at the third instar larvae (RFP) is coincident with the historical trace during development (GFP)
resulting in all cells yellow. (c,d) By contrast, the ectopic expression in the wing disc shows a historical trace (GFP) that is larger than the
current expression at third instar larvae (RFP). Note cells with GFP only signal (arrow heads) and others with coincident GFP+ RFP signal
(asterisks). (e,f ) Akin to Toll-6 (see figure 3), knocking down phantom by RNAi in the posterior wing compartment (en-Gal4>phm-RNAi)
does not alter disc development as judged by the normal expression of Wingless (red). (g,h) Adult wings of genotypes from (e) and (f ).
Note the lack of morphological defects. Bar in (c)= 50 µm.
within the limits of the subset analysed here, all neuronal enhancers display a historical domain which is
larger than that of the final stages of development. This extended domain may be ectopic, in most cases,
and/or transient. The repo enhancer is an exception to this trend. Is this exception marking a difference
between neuron and non-neuron cells?
2.6. A neurosecretory specific enhancer also shows transient and ectopic activity
To further analyse neural cells, other than neurons, we studied a case from the phantom (phm) gene
(electronic supplementary material, table S1). This gene is thought to be specifically expressed in
neurosecretory cells of the prothoracic gland (PG). However, we recently showed that the phm-Gal4
driver is expressed in margin cells of the wing disc [33]. The G-TRACE experiments confirm that cells
in third instar larvae activate the phm enhancer in the PG and in the wing disc (figure 5a–d). The wing
disc also showed historical GFP positive cells at earlier stages of development (figure 5c,d). Thus, this
enhancer of phantom, has ectopic activity in epithelial cells early in development.
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Figure 6. Sex differences in enhancer expression domains. G-TRACE analysis of 4-day-old adult brains expressing LN2-Gal4 (a–e) or
c061-Gal4 (f–j). Female (a,b) and male (c,d) adult brains express the LN2 enhancer during development (GFP) and in its current pattern
(RFP). (e) Quantification of LN2 active cells. (f–i) c061-Gal4 expression pattern. Female (f,g) and male (h,i) adult brains show activity
during development (GFP) and in adulthood (RFP) but, contrary to the case of LN2, there is no evidence of sex differences in the extent
of the expression domain. (j) Quantification of c061 data. Statistics: Student’s t-test *p< 0.05. Number of brains/sample= 5. Bar in
(a)= 50 µm.
We have shown above that Toll-6 expression is not necessary for wing development (figure 3). To
investigate this issue in the case of phm enhancer, we expressed a phantom-RNAi under the control
of an independent early enhancer (engrailed-Gal4) to knock down phantom in the wing disc. Wing
disc morphology, size or the expression of the morphogenetic protein Wingless were not affected
by the ectopic expression of the phantom enhancer (figure 5e,f ). In addition, phm knockdown (en-
Gal4>phmRNAi) does not affect adult wing formation (figure 5g,h). These data suggest that, similar to
Toll-6, even though phantom enhancer is active in the wing disc, phantom gene expression is not required
for wing cell development.
2.7. Sexual dimorphism in the transient enhancer expression
In our study, we included the LN2-Gal4 line that is inserted in the 5′region of the gene sex-lethal (Sxl)
aiming to explore the behaviour of an enhancer in the context of sex. LN2-Gal4 is expressed in a set
of olfactory local and projection neurons that arise from the lateral neuroblasts [34]. We carried out
G-TRACE experiments to verify that LN2-Gal4 expression is restricted to the adult brain and we did
not find early expression during embryonic or larval stages. In the adult brain, we found expression
concentrated in two groups of neurons symmetrically distributed; presumably olfactory interneurons
as it was previously described (figure 6a, arrows). Some additional neurons also activate LN2-Gal4,
particularly in the optic lobes (figure 6a). However, when the historical expression of LN2-Gal4 was
analysed, the number of neurons with earlier expression was noticeably more extensive than the current
expression domain (figure 6b,d,e). Since LN2 was not expressed during embryonic or larval stages, these
supernumerary neurons must have activated the enhancer either during metamorphosis or during the
initial hours of adulthood. Thus, similar to GMR78G09 and GMR10B11 above, LN2 shows transient,
rather than ectopic, expression.
Further analysis revealed that males and females show differences in the activity of this enhancer.
Males display more LN2 expressing cells per brain than females (figure 6c,d,e) and the transcription of
Gal4 in LN2-Gal4 is stronger in males than in females as shown by PCR assays (electronic supplementary
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material, figure S6h). Since the Sxl gene is located in the sexually dimorphic X chromosome, we analysed
if this effect could result from chromosomal dosage compensation. To that end, we tested another neural
Gal4 line inserted in the X chromosome, c061. This line is expressed in the fan-shaped body, dorsal
protocerebrum, mushroom body and dopaminergic neurons [35–37]. The data from adult brains showed
a significant difference between the historical and current expression domains, the former being more
extensive than the latter in line with all other enhancers of this study (figure 6f–j). However, no sex
differences were detected in the expression domains of c061 (figure 6j) or in the transcription levels
of Gal4 (electronic supplementary material, figure S6). To further validate these results, two additional
X-chromosome neural enhancers were tested, 796-Gal4 and elavc155-Gal4. These lines are P-element
insertions in the endogenous ccb [38] and elav [39] genes, respectively (electronic supplementary material,
table S1). 796-Gal4 flies were crossed by UAS-RFP to mark cell membranes and UAS-synaptobrevin-GFP,
to visualize synaptic zones. No sex dimorphism was observed in the volumes of either of these cellular
domains (electronic supplementary material, figure S6a–e). In addition, we compared elavc155-Gal4/G-
TRACE male and female ectopic expression in wing imaginal discs (electronic supplementary material,
figure S2h). No sex differences were detected either in the historical (green) or in the current (red) ectopic
activation pattern of this enhancer (electronic supplementary material, figure S2f,g).
To clarify if the sexual dimorphism observed in LN2-Gal4 was determined by the sex of the cell or
by the peculiar nature of this enhancer, we feminized these cells by co-expressing a construct from the
transformer gene, UAS-traF [40]. In this genotype, the feminized males still show the high number of LN2-
Gal4 expressing neurons as regular males do (electronic supplementary material, figure S6i,j). Thus, the
differential expression of LN2 is an intrinsic feature of this enhancer rather than an indirect consequence
of the sex-determining function of Sxl.
3. Discussion
This study has revealed that enhancers may be activated in ectopic domains early in development. This
non-canonical expression is always transient although it can be sustained until the end of the last larval
stage. However, we have not found evidence that the transient expression of an enhancer leads to the
transient expression of the corresponding gene. The type and extent of the ectopic expression depend on
the enhancer sequence, as well as on the genomic localization site.
In spite of the unstable expression pattern at early stages of development, all enhancers analysed in
this study eventually consolidate into a canonical expression domain that corresponds to the nervous
system. Within the enhancer set analysed here, ectopic domains include preferentially the imaginal discs
(see electronic supplementary material, figure S2f–i). Whether this feature is related to the common
ectodermal origin of neural and epithelial tissues is an issue worth analysing in the future. Other tissues
were routinely screened during the dissection but found mostly negative. Within the nervous system,
some enhancers show ectopic expression meaning that the historical trace of activity spans more neural
cells than the final expression domain. We refer to these cases as transient domains to differentiate them
from the bona fide ectopic expression meaning a different tissue. Transient and ectopic, however, may be
considered two variants of the same phenomenon that differs from the canonical expression.
As enhancers modulate transcriptional activity of promoters, it is important to emphasize that the
phenomenon of transient and/or ectopic enhancer activation is reproduced with different promoters. In
particular, the study of elav was performed with three different transgenic lines. The P-element inserted
in elav locus (elavc155) accounts for native enhancers and promoter. By contrast, elav-Gal4 transgenic lines
inserted in chromosome II and III contain the native sequence of elav enhancer plus a minimal promoter
from the P-element. Despite these differences, in the three cases ectopic activation occurred.
Enhancer activity is determined by chromatin structures and, ultimately, by the binding of protein
complexes to DNA. The Sex lethal enhancer LN2 exhibits sexual dimorphism in its ectopic expression
domain. LN2 is expressed in more cells in males than in females, both in the ectopic and in the canonical
expression domains. All other enhancers analysed do not seem to show sexual dimorphism. Sex lethal is
known to be regulated by splicing mechanisms that determine transcript isoform expression according
to sex [41,42]. Thus, the sex-dependent regulation of LN2 identified here suggests that a different
mechanism must operate on the activation of this enhancer with respect to that of other enhancers.
This alternative mechanism is independent of the sex identity of the cell and it is regulated by intrinsic
characteristics of the enhancer because the feminization of male cells did not alter the sexual dimorphism
in its expression. It is plausible that this feature might reflect sex differences in chromatin structure at
the LN2 locus or in the repertoire of binding transcription factors involved in sex determination. The
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speculations proposed here for the LN2 enhancer of Sxl would be akin to the genomic specializations
described for general sex determination in plants and animals including Drosophila [43–45]. In any case,
it seems that the mechanisms that underlie unstable enhancer expression are diverse but not unspecific.
The ectopic expression identified through the G-TRACE system is not artefactual because it is effective
to trigger the subsequent expression of the coupled gene, illustrated here with basket. Thus, we can
conclude that the observations provided by the G-TRACE technique reflect the normal course of events
during development. That accepted, the question arises of what type of filter the genome uses to
extinguish the unstable expression to finally consolidate a canonical expression domain. Since ectopic
domains may consist of single isolated cells, to relatively large cohorts of adjacent cells, extinction by
signalling from neighbouring cells seems unlikely. For an autonomous cell, perhaps chromatin locus
specific mechanism seems more likely. The case of sex-dependent LN2 enhancer may indicate that the
activation and extinction mechanisms are site specific. We hypothesize that the process of enhancer
activation follows a sequential history in which the early steps are largely variable and refinement into
the canonical domain is progressively built. The molecular microenvironment at the enhancer site, rather
than enhancer sequence, affects the early steps of this process. However, the final expression domain is
determined by the enhancer sequence. The two examples of the elav enhancer analysed here support this
conclusion. It is worth noting that the initial steps of this process, although variable, cannot be considered
random throughout the organism. The ectopic wing expression domains of elav, for example, although
variable among and within larvae, always affect the wing disc and not the fat body, for instance. Thus,
it is likely that the first step in the enhancer activation process may be constrained already to some
extent. This study leaves open, however, the issue of the mechanism to identify and extinguish the ectopic
expression of enhancers. The pillar of evolutionary change is variability and subsequent selection. Thus,
we can envision that the unstable activation of enhancers, although regulated to some extent, could be
modified by any number of factors (e.g. hybridization, heterochromatin rearrangements, viral infections,
environmental clues, etc.) in a way that would escape the filter mechanism for expression extinction and,
thus, eventually result in a change of the canonical expression domain of a gen.
The initial instability in enhancer expression may be relevant to properly evaluate the use of genetic
engineering in biotechnology and the interpretation of a plethora of developmental biology studies
where Gal4 lines are used. It seems appropriate to carry out extensive analyses on the historical
expression of enhancers before launching studies based on the utilitarian use of gen constructs in the,
so-called, selective expression domains.
4. Material and methods
4.1. Drosophila genetics
All fly stocks were maintained at 25°C (unless otherwise specified) on a 12/12 h light/dark cycle at
constant humidity in standard medium. The following stocks were used: elav-Gal4c155 (BL#458), elav-
Gal4 (BL#8765), elav-Gal4 (BL#8760), D42-Gal4 (BL#8816), repo-Gal4 (BL#7415), GH298-Gal4 (BL#37294),
c105 (BL#30822), c061-Gal4 (BL#30845), GMR10B11-Gal4 (BL#48247), GMR78G09-Gal4 (BL#40015),
G-TRACE (BL#28280), G-TRACE (BL#28281), UAS-bsk (BL#9310), Tubulin-Gal80TS (BL#7019), tub-
GAL80TS (BL#7019) Toll-6ex13 (BL#64072), Toll-6-GFP Mi{MIC}Toll-6MI02127 (BL# 34467), P{Act5C-Gal4}
(BL#3954) and (BL#42713), UAS-Tra.F (BL#4590) are from Bloomington Drosophila Stock Center. Line
LN2-Gal4 (NP2426-Gal4, Kyoto#104198) is from Kyoto Stock center, phantom-Gal4 is a gift from M.B.
O’Connor, elav-Gal80 is a gift from G. Morata, 796-Gal4 [38] was generated in our group and OK6-Gal4
[27] is a gift from C. O’Kane.
4.2. Immunostaining
Third instar larvae and adult brains were dissected and fixed with 4% formaldehyde in phosphate-
buffered saline for 20 minutes, washed three times with 0.1% triton, and mounted in Vectashield
mounting medium with DAPI, or incubated with primary antibodies anti-active-caspase 3 (1/100,
Cell Signaling), anti β-gal (1/50, DSHB), anti-elav (1/50, DSHB) or anti-Wingless (1/20, DSHB), and
secondary antibodies Alexa 568 or 647 (Life Technologies). Preparations were imaged by confocal
microscopy with Leica SP5 microscope. Fluorescence quantification was performed with Imaris software.
Images were processed with ImageJ.
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4.3. Statistical analysis
Statistical significance was calculated using a Student’s two-tailed t-test, with significant differences
between compared groups noted by *p< 0.05.
4.4. Live imaging
First and second instar larval wing imaginal discs were visualized and imaged following a previously
published protocol [46].
4.5. Quantitative RT-PCR
Total RNA was isolated from 15 fly heads per genotype (Trizol, Invitrogen); cDNAs were synthesized
with M-MLV RT (Invitrogen). Gal4 Taqman probe (Sc04172924_s1) and RNA-pol II (housekeeping gene)
Taqman probe (Dm02134593) were used (Applied Biosystems). qPCR analysis was done using 7500 Real
Time PCR System (Applied Biosystems) with cycling conditions of 95°C for 10 min and 40 cycles of 95°C
for 15 s and 55°C for 1 min. qPCR results were analysed with 7500 v.2.0.6 software (Applied Biosystems).
4.6. Statement on data and reagent availability
All the strains and reagents are available in the repositories indicated in Materials and methods section.
Electronic supplementary material, table S1 contains all the Gal4 lines tested.
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